DE LUCA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 18.110
EU - Europa 9.979
AS - Asia 9.256
SA - Sud America 1.203
AF - Africa 170
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 15
Totale 38.803
Nazione #
US - Stati Uniti d'America 17.877
GB - Regno Unito 4.052
SG - Singapore 2.747
CN - Cina 2.645
IT - Italia 2.001
HK - Hong Kong 1.352
BR - Brasile 939
SE - Svezia 852
VN - Vietnam 827
DE - Germania 620
FI - Finlandia 478
UA - Ucraina 449
TR - Turchia 365
FR - Francia 351
RU - Federazione Russa 314
KR - Corea 291
IN - India 194
BG - Bulgaria 167
SI - Slovenia 165
JP - Giappone 134
CA - Canada 130
ID - Indonesia 124
NL - Olanda 121
BD - Bangladesh 101
AR - Argentina 84
PL - Polonia 71
IQ - Iraq 65
MX - Messico 64
ZA - Sudafrica 62
AE - Emirati Arabi Uniti 49
ES - Italia 49
IE - Irlanda 49
PK - Pakistan 49
EC - Ecuador 42
BE - Belgio 39
IR - Iran 39
CL - Cile 38
CO - Colombia 37
AT - Austria 36
AU - Australia 36
NZ - Nuova Zelanda 34
UZ - Uzbekistan 33
SA - Arabia Saudita 30
TW - Taiwan 30
PH - Filippine 29
LT - Lituania 27
CZ - Repubblica Ceca 26
MA - Marocco 25
EG - Egitto 22
MY - Malesia 22
VE - Venezuela 22
DK - Danimarca 20
RO - Romania 19
TH - Thailandia 17
DZ - Algeria 16
JO - Giordania 14
QA - Qatar 14
KE - Kenya 13
CH - Svizzera 12
PT - Portogallo 12
PY - Paraguay 12
TN - Tunisia 12
UY - Uruguay 12
IL - Israele 11
KZ - Kazakistan 11
PE - Perù 11
NP - Nepal 10
EU - Europa 9
AZ - Azerbaigian 8
AL - Albania 7
DO - Repubblica Dominicana 7
BY - Bielorussia 6
HU - Ungheria 6
JM - Giamaica 6
KW - Kuwait 6
NI - Nicaragua 6
PS - Palestinian Territory 6
RS - Serbia 6
ET - Etiopia 5
MD - Moldavia 5
OM - Oman 5
GR - Grecia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BO - Bolivia 3
CG - Congo 3
CR - Costa Rica 3
HN - Honduras 3
KH - Cambogia 3
LB - Libano 3
LV - Lettonia 3
MN - Mongolia 3
PA - Panama 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BZ - Belize 2
CI - Costa d'Avorio 2
Totale 38.769
Città #
Southend 3.183
Santa Clara 1.762
Singapore 1.602
Ashburn 1.590
Fairfield 1.534
Hong Kong 1.327
Woodbridge 1.308
Chandler 1.021
Houston 988
Jacksonville 951
Hefei 769
San Jose 727
Dearborn 691
Ann Arbor 619
Wilmington 567
Cambridge 549
Seattle 542
Beijing 483
London 433
Nyköping 380
Helsinki 308
Los Angeles 302
The Dalles 277
Seoul 252
Ho Chi Minh City 249
Hanoi 209
Modena 208
Council Bluffs 196
Milan 181
San Diego 181
Izmir 179
Princeton 179
Sofia 165
Eugene 150
Chicago 145
Lauterbourg 139
New York 133
Des Moines 123
Rome 112
Bologna 102
Buffalo 101
Bari 99
Columbus 97
Moscow 96
Shanghai 88
Jakarta 85
São Paulo 83
Redwood City 82
Falls Church 81
Munich 78
Tokyo 64
Dallas 57
Salt Lake City 51
Boardman 49
Orem 49
Frankfurt am Main 44
Norwalk 40
Warsaw 40
Bremen 38
Dublin 38
Guangzhou 36
Haiphong 36
Kent 32
Auckland 28
Brasília 28
Brooklyn 28
Changsha 28
Belo Horizonte 27
Brussels 27
Chennai 27
Da Nang 27
Elk Grove Village 27
Phoenix 27
Rio de Janeiro 27
Tashkent 27
Xi'an 27
Formigine 26
Nanjing 26
Paris 26
Atlanta 25
Baghdad 25
Reggio Emilia 25
Falkenstein 24
Glasgow 24
Johannesburg 23
Amsterdam 22
Campinas 22
Dhaka 22
Tampa 22
Kunming 21
Medesano 21
Toronto 21
Turku 21
Catania 20
Montreal 20
Redondo Beach 20
Zhengzhou 20
Mexico City 19
Vienna 19
Manchester 18
Totale 27.167
Nome #
Regeneration of the entire human epidermis using transgenic stem cells 832
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 571
Holoclar: first of its kind in more ways than one 526
Applicazioni cliniche dei cheratinociti umani normali coltivati in vitro 474
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 409
Comparative assessment of cultures from oral and urethral stem cells for urethral regeneration 409
Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides 396
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 375
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 363
Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa 362
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 360
Advances in Gene/Cell Therapy in Epidermolysis Bullosa 350
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 349
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 347
Advances in stem cell research and therapeutic development 330
Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes 326
A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording 322
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa 322
Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency 315
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 312
Polarized expression of integrin receptors (a6b4, a2b1, a3b1, avb5) and their relationshipwith the cytoskeleton and basement membrane matrix in cultured human keratinocytes. [5YIF: 10.77; Citations: 127] 305
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union 302
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 297
"HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis 297
Methods for characterization/manipulation of human corneal stem cells and their applications in regenerative medicine. 296
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 293
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. [5YIF: 3.60, Citations: 215] 292
A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status 292
Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography 292
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 291
The long and winding road that leads to a cure for epidermolysis bullosa 291
Chloride transport pathways in human keratinocytes 291
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 287
Gene therapy approaches for epidermolysis bullosa 285
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 285
Clonal analysis of human clonogenic keratinocytes 279
Q-FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells 277
A discussion on cell therapy in Manchester 275
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 274
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 274
Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors 273
Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. 272
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 267
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies 264
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia 264
Stem cell plasticity: time for a reappraisal? 261
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors 261
Corneal Bioengineering 260
Eyes on the prize: Limbal stem cells and corneal restoration 258
Cell biology: Dormant and restless skin stem cells 258
Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. 252
Characterization of chloride transport pathways in cultured human keratinocytes 251
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa 251
Topography and biological role of integrins in human skin 247
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls 246
Corrective transduction of human epidermal stem cells in laminin-5-dependent Junctional Epidermolysis Bullosa. 245
Gene therapy of inherited skin adhesion disorders: a critical overview 243
Towards a gene therapy clinical trial for epidermolysis bullosa 242
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1 242
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis 241
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors 240
Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes 239
p63 identifies keratinocyte stem cells 239
The importance of epidermal stem cells in keratinocyte-mediated gene therapy 239
Stamina therapies: Let the record stand 239
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis 238
HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation 238
Treatment of 'stable' vitiligo by Timedsurgery transplantation of cultured epidermal autografts 238
Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing 234
High expression levels of the "erythroid/brain" type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture 233
Regeneration of squamous epithelia from stem cells of cultured grafts 232
Limbal stem-cell therapy and long-term corneal regeneration. 232
Analysis of the mechanical properties of in vitro reconstructed epidermis: preliminary results 231
Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. 230
The Ocular Albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. 229
Structural and functional studies of integrin receptors in cultured human keratinocytes 228
Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes 227
Advances on potential therapeutic options for epidermolysis bullosa 225
Clonal analysis of stably transduced human epidermal stem cells in culture. 224
Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes 223
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study 223
Ocular Albinism: evidence for a defect in an intracellular signal transduction system. 222
[Inhibition of the biosynthesis of thyroglobulin with propranolol in the rat] 221
Towards therapeutic application of ocular stem cells 220
Stairways to Advanced Therapies for Epidermolysis Bullosa 219
Expression, topography and function of integrin receptors is severely altered in keratinocytes from involved and uninvolved psoriatic skin. 217
CRYOPROTECTIVE AQUEOUS SOLUTIONS USEFUL FOR THE PRESERVATION OF IN VlTRO CULTURED EPITHELIAL SHEETS 217
Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: a multicentre study in the treatment of children 216
Cultivation of human keratinocyte stem cells: current and future clinical applications 215
Transforming Growth-Factor-Beta-1 Modulates Beta-1 And Beta-5 Integrin Receptors And Induces The De-Novo Expression Of The Alpha-V-Beta-6 Heterodimer In Normal Human Keratinocytes - Implications For Wound-Healing. 215
[Inhibition of the biosynthesis of thyroglobulin in the thyroid gland of rats by isoniazid] 214
Toward gene therapy of junctional epidermolysis bullosa (JEB) 211
Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes 211
Culture of human epithelium 209
A multicenter experience in the treatment of burns with autologous and allogeneic cultured epithelium fresh or preserved in a frozen state 207
Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. 207
Transforming Growth-Factor (TGF)-Beta(1) Enhances Alpha(5)Beta(1) And Alpha(V)Beta(5) Integrin Expression And Migration Of Normal Human Keratinocytes 204
Vision from the right stem 202
Biochemical role of FOXM1-dependent histone linker H1B in human epidermal stem cells 201
Corneal epithelial stem-cell transplantation 201
Totale 27.833
Categoria #
all - tutte 139.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021399 0 0 0 0 0 0 0 0 0 0 226 173
2021/20223.152 79 402 235 283 141 250 202 171 343 217 466 363
2022/20233.155 367 336 330 231 363 472 69 285 421 43 139 99
2023/20242.015 76 127 122 159 383 128 116 270 55 224 82 273
2024/20257.260 254 98 174 474 1.267 1.138 567 378 678 268 910 1.054
2025/202610.252 756 651 978 1.033 1.135 931 1.534 624 1.178 1.177 255 0
Totale 39.145